BILL ANALYSIS                                                                                                                                                                                                    Ó



                                                                  AB 1442
                                                                  Page  1

          Date of Hearing:   April 18, 2012

                        ASSEMBLY COMMITTEE ON APPROPRIATIONS
                                Felipe Fuentes, Chair

                 AB 1442 (Wieckowski) - As Amended:  March 27, 2012 

          Policy Committee:                              Environmental 
          Safety and Toxic Materials                    Vote: 8-0

          Urgency:     No                   State Mandated Local Program: 
          Yes    Reimbursable:              No

           SUMMARY  

          This bill authorizes a pharmaceutical waste hauling exemption 
          that allows pharmaceutical waste to be transported according to 
          requirements that are less stringent than those applicable to 
          medical waste.  Specifically, this bill: 

          1)Defines pharmaceutical waste as any pharmaceutical that may no 
            longer be sold or dispensed as a drug.

          2)Creates new documentation requirements of medical waste 
            generators who use a common carrier to transport 
            pharmaceutical waste offsite for treatment and disposal.

          3)Authorizes a medical waste generator to apply for an exemption 
            from medical waste requirements so as to allow pharmaceutical 
            waste to be transported by a common carrier. 

           FISCAL EFFECT  

          1)Annual special fund costs of approximately $280,000 
            (equivalent to three positions) in 2012-13 through 2014-15 to 
            the Department of Public Health-the state agency that enforces 
            medical waste transport-to coordinate with stakeholders 
            statewide, oversee rulemaking process and develop regulations. 
             

          2)Annual special fund costs of approximately $159,000 
            (equivalent to two positions) to the department to review 
            exemption requests and ensure compliance with documentation 
            requirements. 









                                                                  AB 1442
                                                                  Page  2

           COMMENTS  

           1)Rationale  .  The author notes that new pharmaceuticals, as well 
            as unused pharmaceuticals, may be shipped by standard common 
            carrier transport. The author further notes that current law 
            classifies pharmaceutical waste, such as expired or otherwise 
            unusable medications, as medical waste, which generally must 
            be treated, for transport purposes, as hazardous waste.  The 
            author contends this stringent shipping requirement creates 
            costs for hospitals, pharmacies and other medical facilities 
            without increasing public health or safety.

           2)Background  .  The California Medical Waste Management Act 
            defines certain types of waste comprised of pharmaceuticals a 
            biohazardous waste, which must be handled and transported as a 
            hazardous waste, consistent with the California Hazardous 
            Substances Act (CHSA).  According to the Department of Toxic 
            Substance Control, the state agency charged with implementing 
            the CHSA, hazardous waste can be transported only by a 
            registered hazardous waste hauler and compliant with stringent 
            handling requirements. According to DPH, which enforces 
            requirements on the transport of medical waste, there are 
            nearly 11,000 entities in 28 counties that could apply for the 
            exemption to medical waste transport requirement provided by 
            this bill.  
                
            3)Support  .  This bill is supported by EXP Pharmaceutical 
            Services (sponsor), the California Product Stewardship Council 
            and several other organizations.

           4)There is no formal opposition registered to this bill.     

           Analysis Prepared by  :    Jay Dickenson / APPR. / (916) 319-2081